相关实验视频
Updated: May 5, 2026

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
15.5K
在高风险的基底细胞癌患者中复发的临床病理预测因素,回顾性分析
Nora Abdelhafiz1, Abdallah H Mohamed2, Mohamed Hussein Mahran3
1Department of Radiotherapy and Nuclear Medicine, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
International journal of surgical pathology
|March 3, 2026
概括
瘤的芽和瘤透的淋巴细胞的低水平预测了基底细胞癌的复发. 辅助放射治疗显著改善高风险患者的无疾病生存率.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 高风险的基底细胞癌 (BCC) 在预测复发和生存方面存在挑战.
- 确定可靠的预后因素对于有效的患者管理至关重要.
研究的目的:
- 确定高风险BCC中复发和无病生存的关键预后因素.
- 评估瘤芽,瘤透淋巴细胞和辅助放射治疗的作用.
主要方法:
- 在5年内对34名高风险结节性BCC患者进行了回顾性队列研究.
- 对临床病理学数据的分析,包括瘤芽和瘤透淋巴细胞得分.
- 评估影响复发和无疾病生存的因素,使用几率比率.
主要成果:
- 瘤芽 (OR 3.6) 和低瘤透淋巴细胞 (OR 4.5) 与复发有显著的相关性.
- 不接受辅助放射治疗的患者有更高的复发风险 (OR 5.2).
- 五年无病生存率总体为47%,放射治疗为80%,没有放射治疗为0%.
结论:
- 瘤芽和低瘤透淋巴细胞是高风险BCC中不良结果的强有力的预测因素.
- 辅助放射治疗显著改善了晚期BCC患者的无疾病生存率.
- 这些标记可以帮助个性化规划高风险BCC的治疗.
相关概念视频
Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870

